General

Showing 1313–1328 of 2301 results

Article: O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
€3.03 Add to cart
Article: O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS
€3.03 Add to cart
Article: O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies
€3.03 Add to cart
Article: O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin
€3.03 Add to cart
Article: O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease
€3.03 Add to cart
Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment
€3.03 Add to cart
Article: O.3 The anti-angiogenic peptide Anginex blocks osteoclastogenesis
€3.03 Add to cart
Article: O.4 An in-depth investigation of the causes of treatment failure in AML
€3.03 Add to cart
Article: O.4 Combination of regulatory T cells injection with rapamycin for treatment of chronic Graft-versus-Host disease
€3.03 Add to cart
Article: O.4 Functional characterization of activating mutants of the JAK3 tyrosine kinase implicated in tumoral transformation of T lymphocytes
€3.03 Add to cart
Article: O.4 Impact of pre-transplant infusion of antithymocyte globulin (ATG-Fresenius) on immune recovery after high intensity conditioning allogeneic stem cell transplantation
€3.03 Add to cart
Article: O.4 In vitro generation of tumor antigen-specific T cells from patient and healthy donor stem cells
€3.03 Add to cart
Article: O.4 SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
€3.03 Add to cart
Article: O.5 Azacytidine augments regulatory T cells and prevents experimental xenogeneic graft-versus-host disease
€3.03 Add to cart
Article: O.5 BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival
€3.03 Add to cart
Article: O.5 Confirmation of the very low rate of subclinical venous thrombosis in people with hemophilia undergoing major orthopedic surgery in the absence of pharmacological thromboprophylaxis
€3.03 Add to cart

Article: O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

Article: O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS

Article: O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Article: O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin

Article: O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease

Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment

Article: O.3 The anti-angiogenic peptide Anginex blocks osteoclastogenesis

Article: O.4 An in-depth investigation of the causes of treatment failure in AML

Article: O.4 Combination of regulatory T cells injection with rapamycin for treatment of chronic Graft-versus-Host disease

Article: O.4 Functional characterization of activating mutants of the JAK3 tyrosine kinase implicated in tumoral transformation of T lymphocytes

Article: O.4 Impact of pre-transplant infusion of antithymocyte globulin (ATG-Fresenius) on immune recovery after high intensity conditioning allogeneic stem cell transplantation

Article: O.4 In vitro generation of tumor antigen-specific T cells from patient and healthy donor stem cells

Article: O.4 SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma

Article: O.5 Azacytidine augments regulatory T cells and prevents experimental xenogeneic graft-versus-host disease

Article: O.5 BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival

Article: O.5 Confirmation of the very low rate of subclinical venous thrombosis in people with hemophilia undergoing major orthopedic surgery in the absence of pharmacological thromboprophylaxis